Market revenue in 2020 | USD 149.1 million |
Market revenue in 2028 | USD 249.7 million |
Growth rate | 6.7% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables, Services |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 63.11% in 2024. Horizon Databook has segmented the Singapore infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
Being a high-ranked healthcare system, the infectious respiratory disease diagnostics market in Singapore is likely to witness lucrative growth due to expansion of healthcare delivery systems. Initiatives aimed at promoting R&D in medical diagnostics are contributing to the steady growth of market.
For instance, in October 2019, ASEAN Ministerial Meeting on Science, Technology and Innovation (AMMSTI-18) and ASEAN Committee on Science, Technology and Innovation (COSTI77) launched a project for the development of diagnostics solutions under the Diagnostics Development Hub (DXD Hub), an initiative launched by Singapore Agency for Science and Technology Research to facilitate development & commercialization of diagnostic tests in the country.
With this hub, Singapore is expected to increase growth opportunities for new and existing companies to develop diagnostic assets. Moreover, the introduction of innovative products for medical imaging and the availability of testing products for disease screening are anticipated to fuel the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Singapore infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account